--- title: "ALR Technologies SG (ALRTF) stock: news and investor profile" url: "https://aibio.space/companies/alr-technologies-sg/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ALR Technologies SG Ltd. (OTC: ALRTF), United States. Listing facts, related biotech companies and news on aibio.space." --- ALRTF ALR Technologies SG Ltd. OTC · United States # ALR Technologies SG (ALRTF) news ALR Technologies SG Ltd. is a public biotech or pharmaceutical company listed on OTC under the ticker ALRTF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest ALR Technologies SG news We have not published a story on ALR Technologies SG yet. When there is news, it will appear here. ## ALR Technologies SG at a glance - **Ticker**: ALRTF - **Listing**: OTC - **Country**: United States - **Cash, Dec 31, 2025**: $20,305 ### Related companies - [Bausch & Lomb](https://aibio.space/companies/bausch-lomb/) NYSE: BLCO - [Target Group](https://aibio.space/companies/target/) OTC: CBDY - [Mobia Medical](https://aibio.space/companies/mobia-medical/) NASDAQ: MOBI - [Yubo International Biotech](https://aibio.space/companies/yubo-international-biotech/) OTC: YBGJ - [National Vision Holdings](https://aibio.space/companies/national-vision/) NASDAQ: EYE - [Prenetics Global](https://aibio.space/companies/prenetics-global/) NASDAQ: PRE - [ILLUMINA, INC.](https://aibio.space/companies/illumina/) NASDAQ: ILMN - [Profound Medical](https://aibio.space/companies/profound-medical/) NASDAQ: PROF ### Also on OTC - [Adaptimmune Therapeutics](https://aibio.space/companies/adaptimmune-therapeutics/) ADAPY - [PROCYON CORP](https://aibio.space/companies/procyon/) PCYN - [BIOTRICITY INC.](https://aibio.space/companies/biotricity/) BTCY - [NANOLOGIX INC](https://aibio.space/companies/nanologix/) NNLX - [Vaxxinity](https://aibio.space/companies/vaxxinity/) VAXX - [TFA Therapeutics](https://aibio.space/companies/tfa-therapeutics/) RAJAF ## What ALR Technologies SG does ALR Technologies SG Ltd. describes itself as a data management company with a comprehensive approach to diabetes care. Its Diabetes Solution product collects data from blood glucose meters (BGM) and continuous glucose monitors (CGM), and it is FDA-cleared and HIPAA-compliant. Its technology portfolio also includes a patent pending Predictive A1C algorithm that tracks treatment success between lab reports, and an FDA-cleared Insulin Dosing Adjustment program. The company says it is actively seeking to commence revenue-generating activities for the Diabetes Solution. It also developed GluCurve, a version for animal health, sold as the GluCurve Pet CGM. In 2022 it entered a co-branded distribution agreement with Covetrus, Inc. for the GluCurve Pet CGM, which expired while the company evaluated new CGM suppliers. On September 19, 2025 it entered a manufacturing agreement with CGM Medical Technology Shen Zhen Ltd., subject to the hardware meeting its specifications. Earlier, it agreed with Bionime Corporation to bundle the Diabetes Solution with blood glucose test supplies for private clinics in Singapore, and a 24-week pilot with Singapore General Hospital reported a mean drop of 1.2 percent in HbA1c. | Product or program | What it is | Stage | |---|---|---| | Diabetes Solution | Data management product collecting BGM and CGM data for diabetes care | FDA-cleared | | Insulin Dosage Adjustment technology | Insulin dosing adjustment program | FDA-cleared | | Predictive A1C | Algorithm tracking treatment success between lab reports | patent application filed under the PCT | | GluCurve Pet CGM | Continuous glucose monitor for animal health | relaunch under discussion | Summarised from the company's [20-F filed Apr 30, 2026](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/alrt_20f.htm). ## ALR Technologies SG annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$793,327](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | [$883,866](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | | Net income (loss) | [-$22.1 million](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | [-$15.9 million](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | | Cash from operations | [-$1.9 million](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | [-$1.5 million](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | | Cash and equivalents | [$20,305](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | [$40,657](https://www.sec.gov/Archives/edgar/data/1930419/000190359626000182/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $20,305. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ALR Technologies SG What is the ticker symbol of ALR Technologies SG? ALR Technologies SG Ltd. trades under the ticker ALRTF on OTC. Where is ALR Technologies SG listed? ALR Technologies SG Ltd. is listed on OTC. Which country or territory is ALR Technologies SG listed under? Our directory records ALR Technologies SG Ltd. under United States. Does aibio.space cover ALR Technologies SG? aibio.space lists ALR Technologies SG Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. What does ALR Technologies SG develop? ALR Technologies SG Ltd. describes itself as a data management company with a comprehensive approach to diabetes care. Its Diabetes Solution product collects data from blood glucose meters (BGM) and continuous glucose monitors (CGM), and it is FDA-cleared and HIPAA-compliant. What is Diabetes Solution from ALR Technologies SG? Diabetes Solution: Data management product collecting BGM and CGM data for diabetes care Stage: FDA-cleared. What is Insulin Dosage Adjustment technology from ALR Technologies SG? Insulin Dosage Adjustment technology: Insulin dosing adjustment program Stage: FDA-cleared. Is ALR Technologies SG profitable? ALR Technologies SG Ltd. reported a net loss of $22.1 million for the fiscal year ended Dec 31, 2025, and used $1.9 million of cash in operations, per its annual report to the SEC. How much does ALR Technologies SG spend on research and development? $793,327 in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does ALR Technologies SG have? $20,305 in cash at Dec 31, 2025, per its 20-F. ## Investor discussion: ALR Technologies SG Members talk about ALR Technologies SG (ALRTF). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:ALRTF on TradingView](https://www.tradingview.com/symbols/OTC-ALRTF/). ## Listing details ALR Technologies SG Ltd. is a public biotech or pharmaceutical company listed on OTC under the ticker ALRTF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ALR Technologies SG Ltd. - **Ticker**: ALRTF - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/alr-technologies-sg/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ALR Technologies SG (ALRTF) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/alr-technologies-sg/